Deepa Sridharan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Deepa Sridharan has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Takashi Angata
Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan
3 shared publications - An-Yu Chen
Institute of Preventive Medicine, National Defense Medical Center, Taipei, Taiwan
1 shared publication - Avijit Kumar Adak
Department of Chemistry, National Tsing Hua University, Hsinchu 300044, Taiwan
1 shared publication Chen-Yo Fan
Department of Chemistry, National Tsing-Hua University, Hsinchu, 30013, Taiwan
1 shared publicationChih-Heng Huang
Institute of Preventive Medicine, National Defense Medical Center, Taipei, Taiwan
1 shared publicationChih-Ta Chien
Institute of Biological Chemistry, Academia Sinica, Taipei 11529, Taiwan
1 shared publication
Latest Publications
- Open Access
- 18 August 2026
- Published by Springer Nature in Communications Biology
Unraveling the immune landscape and molecular signatures of antibody-dependent cellular cytotoxicity in SARS-CoV-2 clearance
- 18 August 2026
- Published by Springer Nature in Communications Biology
Open AccessUnraveling the immune landscape and molecular signatures of antibody-dependent cellular cytotoxicity in SARS-CoV-2 clearance
- Open Access
- 13 June 2023
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 3 (7) , 1864-1875
High Density of N- and O-Glycosylation Shields and Defines the Structural Dynamics of the Intrinsically Disordered Ectodomain of Receptor-type Protein Tyrosine Phosphatase Alpha
The intracellular phosphatase domain of the receptor-type protein tyrosine phosphatase alpha (PTPRA) is known to regulate various signaling pathways related to cell adhesion through c-Src kinase activation. In contrast, the functional significance of its relatively short, intrinsically disordered, and heavily glycosylated ectodomain remains unclear. Through detailed mass spectrometry analyses of a combination of protease and glycosidase digests, we now provide the first experimental evidence for its site-specific glycosylation pattern. This includes the occurrence of O-glycan at the N-glycosylation sequon among the more than 30 O-glycosylation sites confidently identified beside the 7 N-glycosylation sites. The closely spaced N- and O-glycans appear to have mutually limited the extent of further galactosylation and sialylation. An immature smaller form of full-length PTPRA was found to be deficient in O-glycosylation, most likely due to failure to transit the Golgi. N-glycosylation, on the other hand, is dispensable for cell surface expression and contributes less than the extensive O-glycosylation to the overall solution structure of the ectodomain. The glycosylation information is combined with the overall structural features of the ectodomain derived from small-angle X-ray scattering and high-speed atomic force microscopy monitoring to establish a dynamic structural model of the densely glycosylated PTPRA ectodomain. The observed high structural flexibility, as manifested by continuous transitioning from fully to partially extended and fold-back conformations, suggests that the receptor-type phosphatase is anchored to the membrane and kept mostly at a monomeric state through an ectodomain shaped and fully shielded by glycosylation.
- 13 June 2023
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 3 (7) , 1864-1875
Open AccessHigh Density of N- and O-Glycosylation Shields and Defines the Structural Dynamics of the Intrinsically Disordered Ectodomain of Receptor-type Protein Tyrosine Phosphatase Alpha
The intracellular phosphatase domain of the receptor-type protein tyrosine phosphatase alpha (PTPRA) is known to regulate various signaling pathways related to cell adhesion through c-Src kinase activation. In contrast, the functional significance of its relatively short, intrinsically disordered, and heavily glycosylated ectodomain remains unclear. Through detailed mass spectrometry analyses of a combination of protease and glycosidase digests, we now provide the first experimental evidence for its site-specific glycosylation pattern. This includes the occurrence of O-glycan at the N-glycosylation sequon among the more than 30 O-glycosylation sites confidently identified beside the 7 N-glycosylation sites. The closely spaced N- and O-glycans appear to have mutually limited the extent of further galactosylation and sialylation. An immature smaller form of full-length PTPRA was found to be deficient in O-glycosylation, most likely due to failure to transit the Golgi. N-glycosylation, on the other hand, is dispensable for cell surface expression and contributes less than the extensive O-glycosylation to the overall solution structure of the ectodomain. The glycosylation information is combined with the overall structural features of the ectodomain derived from small-angle X-ray scattering and high-speed atomic force microscopy monitoring to establish a dynamic structural model of the densely glycosylated PTPRA ectodomain. The observed high structural flexibility, as manifested by continuous transitioning from fully to partially extended and fold-back conformations, suggests that the receptor-type phosphatase is anchored to the membrane and kept mostly at a monomeric state through an ectodomain shaped and fully shielded by glycosylation.
- 25 January 2022
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 232, 114146
Sugar nucleotide regeneration system for the synthesis of Bi- and triantennary N-glycans and exploring their activities against siglecs
- 25 January 2022
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 232, 114146
Sugar nucleotide regeneration system for the synthesis of Bi- and triantennary N-glycans and exploring their activities against siglecs